|
WO2008027558A2
(en)
|
2006-08-31 |
2008-03-06 |
Codon Devices, Inc. |
Iterative nucleic acid assembly using activation of vector-encoded traits
|
|
CN103502448B
(zh)
|
2010-11-12 |
2017-03-29 |
Gen9股份有限公司 |
核酸合成的方法和设备
|
|
EP4039363A1
(en)
|
2010-11-12 |
2022-08-10 |
Gen9, Inc. |
Protein arrays and methods of using and making the same
|
|
BR112013024337A2
(pt)
|
2011-03-23 |
2017-09-26 |
Du Pont |
locus de traço transgênico complexo em uma planta, planta ou semente, método para produzir em uma planta um locus de traço transgênico complexo e construto de expressão
|
|
CA2853829C
(en)
|
2011-07-22 |
2023-09-26 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
IL302248A
(en)
|
2011-08-26 |
2023-06-01 |
Gen9 Inc |
Compositions and methods for high fidelity assembly of nucleic acids
|
|
JP2014531908A
(ja)
|
2011-10-14 |
2014-12-04 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
構造アッセンブリによる配列決定
|
|
ES2991004T3
(es)
|
2011-12-22 |
2024-12-02 |
Harvard College |
Métodos para la detección de analitos
|
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
|
US9150853B2
(en)
|
2012-03-21 |
2015-10-06 |
Gen9, Inc. |
Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
|
|
WO2013163263A2
(en)
|
2012-04-24 |
2013-10-31 |
Gen9, Inc. |
Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
|
|
US9834786B2
(en)
|
2012-04-25 |
2017-12-05 |
Regeneron Pharmaceuticals, Inc. |
Nuclease-mediated targeting with large targeting vectors
|
|
EP2841572B1
(en)
|
2012-04-27 |
2019-06-19 |
Duke University |
Genetic correction of mutated genes
|
|
US10266850B2
(en)
|
2012-05-25 |
2019-04-23 |
The Regents Of The University Of California |
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
|
|
BR112014031891A2
(pt)
|
2012-06-19 |
2017-08-01 |
Univ Minnesota |
direcionamento genético nas plantas utilizando vírus de dna
|
|
EP3483311B8
(en)
|
2012-06-25 |
2025-10-29 |
Ginkgo Bioworks, Inc. |
Methods for nucleic acid assembly and high throughput sequencing
|
|
KR20230065381A
(ko)
|
2012-07-25 |
2023-05-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
|
|
CN110669758A
(zh)
|
2012-10-23 |
2020-01-10 |
基因工具股份有限公司 |
用于切割靶dna 的组合物及其用途
|
|
EP2920319B1
(en)
|
2012-11-16 |
2020-02-19 |
Poseida Therapeutics, Inc. |
Site-specific enzymes and methods of use
|
|
CA3034794A1
(en)
|
2012-12-06 |
2014-06-12 |
Sigma-Aldrich Co. Llc |
Crispr-based genome modification and regulation
|
|
EP2940140B1
(en)
|
2012-12-12 |
2019-03-27 |
The Broad Institute, Inc. |
Engineering of systems, methods and optimized guide compositions for sequence manipulation
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
EP4234696A3
(en)
|
2012-12-12 |
2023-09-06 |
The Broad Institute Inc. |
Crispr-cas component systems, methods and compositions for sequence manipulation
|
|
EP3434776A1
(en)
|
2012-12-12 |
2019-01-30 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
|
WO2014093701A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
|
WO2014093655A2
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
|
|
RU2721275C2
(ru)
|
2012-12-12 |
2020-05-18 |
Те Брод Инститьют, Инк. |
Доставка, конструирование и оптимизация систем, способов и композиций для манипуляции с последовательностями и применения в терапии
|
|
CN105121648B
(zh)
*
|
2012-12-12 |
2021-05-07 |
布罗德研究所有限公司 |
用于序列操纵的系统、方法和优化的指导组合物的工程化
|
|
AU2013359212B2
(en)
|
2012-12-12 |
2017-01-19 |
Massachusetts Institute Of Technology |
Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
|
|
EP2931891B1
(en)
*
|
2012-12-17 |
2019-05-15 |
President and Fellows of Harvard College |
Rna-guided human genome engineering
|
|
JP2016507244A
(ja)
*
|
2013-02-27 |
2016-03-10 |
ヘルムホルツ・ツェントルム・ミュンヒェン・ドイチェス・フォルシュンクスツェントルム・フューア・ゲズントハイト・ウント・ウムベルト（ゲーエムベーハー）Ｈｅｌｍｈｏｌｔｚ Ｚｅｎｔｒｕｍ ＭｕｅｎｃｈｅｎＤｅｕｔｓｃｈｅｓ Ｆｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ ｆｕｅｒ Ｇｅｓｕｎｄｈｅｉｔ ｕｎｄ Ｕｍｗｅｌｔ （ＧｍｂＨ） |
Ｃａｓ９ヌクレアーゼによる卵母細胞における遺伝子編集
|
|
EP2971184B1
(en)
|
2013-03-12 |
2019-04-17 |
President and Fellows of Harvard College |
Method of generating a three-dimensional nucleic acid containing matrix
|
|
DK3620534T3
(da)
*
|
2013-03-14 |
2021-12-06 |
Caribou Biosciences Inc |
Crispr-cas sammensætninger af nucleinsyre-targeting nucleinsyrer
|
|
KR102271291B1
(ko)
*
|
2013-03-15 |
2021-07-02 |
더 제너럴 하스피탈 코포레이션 |
특정 게놈 좌위에 대한 유전적 및 후성적 조절 단백질의 rna-안내 표적화
|
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
|
MX376838B
(es)
*
|
2013-03-15 |
2025-03-07 |
Univ Minnesota |
Ingenieria genomica de plantas utilizando sistemas crispr/cas.
|
|
US20140273230A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
|
US9828582B2
(en)
|
2013-03-19 |
2017-11-28 |
Duke University |
Compositions and methods for the induction and tuning of gene expression
|
|
US20160186208A1
(en)
*
|
2013-04-16 |
2016-06-30 |
Whitehead Institute For Biomedical Research |
Methods of Mutating, Modifying or Modulating Nucleic Acid in a Cell or Nonhuman Mammal
|
|
LT2986729T
(lt)
|
2013-04-16 |
2018-10-25 |
Regeneron Pharmaceuticals, Inc. |
Žiurkės genomo tikslinė modifikacija
|
|
JP2016521975A
(ja)
|
2013-05-15 |
2016-07-28 |
サンガモ バイオサイエンシーズ， インコーポレイテッド |
遺伝的状態の処置のための方法および組成物
|
|
WO2014191518A1
(en)
*
|
2013-05-29 |
2014-12-04 |
Cellectis |
A method for producing precise dna cleavage using cas9 nickase activity
|
|
US9267135B2
(en)
|
2013-06-04 |
2016-02-23 |
President And Fellows Of Harvard College |
RNA-guided transcriptional regulation
|
|
AU2014274939B2
(en)
|
2013-06-04 |
2020-03-19 |
President And Fellows Of Harvard College |
RNA-guideded transcriptional regulation
|
|
CN105658805B
(zh)
*
|
2013-06-05 |
2021-12-31 |
杜克大学 |
Rna指导的基因编辑和基因调节
|
|
EP3008186B1
(en)
|
2013-06-14 |
2018-11-28 |
Cellectis |
Methods for non-transgenic genome editing in plants
|
|
WO2014204729A1
(en)
*
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components
|
|
BR112015031608A2
(pt)
|
2013-06-17 |
2017-08-22 |
Massachusetts Inst Technology |
Aplicação e uso dos sistemas crispr-cas, vetores e composições para direcionamento e terapia hepáticos
|
|
CA2915837A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute, Inc. |
Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
|
|
EP3725885A1
(en)
|
2013-06-17 |
2020-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
|
AU2014281030B2
(en)
*
|
2013-06-17 |
2020-07-09 |
Massachusetts Institute Of Technology |
Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells
|
|
EP3011029B1
(en)
|
2013-06-17 |
2019-12-11 |
The Broad Institute, Inc. |
Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
|
|
US10011850B2
(en)
|
2013-06-21 |
2018-07-03 |
The General Hospital Corporation |
Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
|
|
BR112016000571B1
(pt)
*
|
2013-07-10 |
2023-12-26 |
President And Fellows Of Harvard College |
Métodos in vitro para modular a expressão e para alterar um ou mais ácidos nucleicos alvo em uma célula simultaneamente com a regulação da expressão de um ou mais ácidos nucleicos alvo em uma célula, bem como célula de levedura ou bactéria compreendendo ácidos nucleicos
|
|
US10563225B2
(en)
|
2013-07-26 |
2020-02-18 |
President And Fellows Of Harvard College |
Genome engineering
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
BR112016003591A8
(pt)
|
2013-08-22 |
2018-01-30 |
Du Pont |
promotor u6 de polimerase iii de soja e métodos de uso
|
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
ES3013744T3
(en)
*
|
2013-09-18 |
2025-04-15 |
Kymab Ltd |
Methods, cells and organisms
|
|
WO2015065964A1
(en)
|
2013-10-28 |
2015-05-07 |
The Broad Institute Inc. |
Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof
|
|
WO2015066119A1
(en)
|
2013-10-30 |
2015-05-07 |
North Carolina State University |
Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
|
|
EP3066201B1
(en)
|
2013-11-07 |
2018-03-07 |
Editas Medicine, Inc. |
Crispr-related methods and compositions with governing grnas
|
|
LT3080279T
(lt)
|
2013-12-11 |
2018-10-25 |
Regeneron Pharmaceuticals, Inc. |
Būdai ir kompozicijos, skirti genomo tikslinei modifikacijai
|
|
CN110951779B
(zh)
|
2013-12-11 |
2024-04-16 |
瑞泽恩制药公司 |
用于靶向修饰基因组的方法和组合物
|
|
EP3080257A1
(en)
|
2013-12-12 |
2016-10-19 |
The Broad Institute Inc. |
Compositions and methods of use of crispr-cas systems in nucleotide repeat disorders
|
|
MX374529B
(es)
|
2013-12-12 |
2025-03-06 |
Broad Inst Inc |
Suministro, uso y aplicaciones terapeuticas de sistemas y composiciones crispr-cas para edicion del genoma.
|
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
|
EP4219699A1
(en)
|
2013-12-12 |
2023-08-02 |
The Broad Institute, Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
|
EP3080261B1
(en)
|
2013-12-12 |
2019-05-22 |
The Broad Institute, Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for hbv and viral diseases and disorders
|
|
US9840699B2
(en)
|
2013-12-12 |
2017-12-12 |
President And Fellows Of Harvard College |
Methods for nucleic acid editing
|
|
AU2014361834B2
(en)
|
2013-12-12 |
2020-10-22 |
Massachusetts Institute Of Technology |
CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes
|
|
WO2015089486A2
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
|
US10787654B2
(en)
*
|
2014-01-24 |
2020-09-29 |
North Carolina State University |
Methods and compositions for sequence guiding Cas9 targeting
|
|
DE212015000061U1
(de)
|
2014-02-11 |
2017-09-03 |
The Regents Of The University Of Colorado, A Body Corporate |
CRISPR-ermöglichtes Multiplex Genom Engineering
|
|
CA2940084A1
(en)
|
2014-02-18 |
2015-08-27 |
Duke University |
Compositions for the inactivation of virus replication and methods of making and using the same
|
|
WO2015134812A1
(en)
|
2014-03-05 |
2015-09-11 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa
|
|
DK3116997T3
(da)
|
2014-03-10 |
2019-08-19 |
Editas Medicine Inc |
Crispr/cas-relaterede fremgangsmåder og sammensætninger til behandling af lebers kongenitale amaurose 10 (lca10)
|
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
WO2015148670A1
(en)
*
|
2014-03-25 |
2015-10-01 |
Editas Medicine Inc. |
Crispr/cas-related methods and compositions for treating hiv infection and aids
|
|
EP3981876A1
(en)
|
2014-03-26 |
2022-04-13 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating sickle cell disease
|
|
EP3126495A1
(en)
|
2014-04-02 |
2017-02-08 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating primary open angle glaucoma
|
|
JP2017512481A
(ja)
|
2014-04-08 |
2017-05-25 |
ノースカロライナ ステート ユニバーシティーＮｏｒｔｈ Ｃａｒｏｌｉｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ |
Ｃｒｉｓｐｒ関連遺伝子を用いた、ｒｎａ依存性の転写抑制のための方法および組成物
|
|
AP2016009588A0
(en)
|
2014-04-28 |
2016-11-30 |
Recombinetics Inc |
Multiplex gene editing in swine
|
|
WO2015188065A1
(en)
|
2014-06-05 |
2015-12-10 |
Sangamo Biosciences, Inc. |
Methods and compositions for nuclease design
|
|
SG11201609634YA
(en)
|
2014-06-06 |
2016-12-29 |
Regeneron Pharma |
Methods and compositions for modifying a targeted locus
|
|
CN106852157B
(zh)
*
|
2014-06-16 |
2022-04-12 |
约翰斯·霍普金斯大学 |
用于使用h1启动子表达crispr向导rna的组合物和方法
|
|
AU2015277180A1
(en)
*
|
2014-06-17 |
2017-01-12 |
Poseida Therapeutics, Inc. |
A method for directing proteins to specific loci in the genome and uses thereof
|
|
US9738897B2
(en)
|
2014-06-23 |
2017-08-22 |
Regeneron Pharmaceuticals, Inc. |
Nuclease-mediated DNA assembly
|
|
PL3161128T3
(pl)
|
2014-06-26 |
2019-02-28 |
Regeneron Pharmaceuticals, Inc. |
Sposoby i kompozycje do celowanych modyfikacji genetycznych i sposoby zastosowania
|
|
EP3167071B1
(en)
*
|
2014-07-09 |
2020-10-07 |
Gen9, Inc. |
Compositions and methods for site-directed dna nicking and cleaving
|
|
WO2016007839A1
(en)
|
2014-07-11 |
2016-01-14 |
President And Fellows Of Harvard College |
Methods for high-throughput labelling and detection of biological features in situ using microscopy
|
|
CA2954791C
(en)
*
|
2014-07-14 |
2025-11-18 |
The Regents Of The University Of California |
CRISPR/CAS TRANSCRIPTIONAL MODULATION
|
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
CN113789317B
(zh)
*
|
2014-08-06 |
2024-02-23 |
基因工具股份有限公司 |
使用空肠弯曲杆菌crispr/cas系统衍生的rna引导的工程化核酸酶的基因编辑
|
|
US10450584B2
(en)
|
2014-08-28 |
2019-10-22 |
North Carolina State University |
Cas9 proteins and guiding features for DNA targeting and genome editing
|
|
US10570418B2
(en)
|
2014-09-02 |
2020-02-25 |
The Regents Of The University Of California |
Methods and compositions for RNA-directed target DNA modification
|
|
US11560568B2
(en)
|
2014-09-12 |
2023-01-24 |
E. I. Du Pont De Nemours And Company |
Generation of site-specific-integration sites for complex trait loci in corn and soybean, and methods of use
|
|
CN107002078A
(zh)
*
|
2014-10-09 |
2017-08-01 |
生命技术公司 |
Crispr寡核苷酸和基因剪辑
|
|
WO2016057850A1
(en)
*
|
2014-10-09 |
2016-04-14 |
Seattle Children' S Hospital (Dba Seattle Children' S Research Institute) |
Long poly (a) plasmids and methods for introduction of long poly (a) sequences into the plasmid
|
|
CA2963693A1
(en)
|
2014-10-10 |
2016-04-14 |
Editas Medicine, Inc. |
Compositions and methods for promoting homology directed repair
|
|
DK3207124T3
(da)
|
2014-10-15 |
2019-08-12 |
Regeneron Pharma |
Fremgangsmåder og sammensætninger til generering eller bevaring af pluripotente celler
|
|
US20170306306A1
(en)
*
|
2014-10-24 |
2017-10-26 |
Life Technologies Corporation |
Compositions and Methods for Enhancing Homologous Recombination
|
|
GB201418965D0
(enExample)
|
2014-10-24 |
2014-12-10 |
Ospedale San Raffaele And Fond Telethon |
|
|
TWI716367B
(zh)
*
|
2014-10-31 |
2021-01-21 |
麻省理工學院 |
用於常間回文重複序列叢集（ｃｒｉｓｐｒ）之大量平行組合性基因學
|
|
DK3597740T3
(da)
*
|
2014-11-06 |
2022-06-20 |
Dupont Us Holding Llc |
Peptidmedieret indføring af rna-styret endonuklease i celler
|
|
AU2015342749B2
(en)
|
2014-11-07 |
2022-01-27 |
Editas Medicine, Inc. |
Methods for improving CRISPR/Cas-mediated genome-editing
|
|
CN107532142A
(zh)
*
|
2014-11-11 |
2018-01-02 |
应用干细胞有限公司 |
使用同源重组改造间充质干细胞
|
|
KR20160059994A
(ko)
|
2014-11-19 |
2016-05-27 |
기초과학연구원 |
두 개의 벡터로부터 발현된 Cas9 단백질을 이용한 유전자 발현 조절 방법
|
|
CA3176380A1
(en)
|
2014-11-21 |
2016-05-26 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for targeted genetic modification using paired guide rnas
|
|
GB201421096D0
(en)
|
2014-11-27 |
2015-01-14 |
Imp Innovations Ltd |
Genome editing methods
|
|
CA2969619A1
(en)
|
2014-12-03 |
2016-06-09 |
Agilent Technologies, Inc. |
Guide rna with chemical modifications
|
|
JP6830437B2
(ja)
|
2014-12-10 |
2021-02-17 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
疾患を処置するための遺伝子改変された細胞、組織および臓器
|
|
EP3985115A1
(en)
|
2014-12-12 |
2022-04-20 |
The Broad Institute, Inc. |
Protected guide rnas (pgrnas)
|
|
CN119320775A
(zh)
*
|
2014-12-18 |
2025-01-17 |
综合基因技术公司 |
基于crispr的组合物和使用方法
|
|
EP3653048B9
(en)
|
2014-12-19 |
2023-10-04 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for targeted genetic modification through single-step multiple targeting
|
|
WO2016100857A1
(en)
|
2014-12-19 |
2016-06-23 |
Regeneron Pharmaceuticals, Inc. |
Stem cells for modeling type 2 diabetes
|
|
EP3702456A1
(en)
|
2014-12-24 |
2020-09-02 |
The Broad Institute, Inc. |
Crispr having or associated with destabilization domains
|
|
ES2894882T3
(es)
|
2015-01-29 |
2022-02-16 |
Meiogenix |
Procedimiento para inducir recombinaciones meióticas dirigidas
|
|
WO2016130600A2
(en)
|
2015-02-09 |
2016-08-18 |
Duke University |
Compositions and methods for epigenome editing
|
|
AU2016246450B2
(en)
|
2015-04-06 |
2022-03-17 |
Agilent Technologies, Inc. |
Chemically modified guide RNAs for CRISPR/Cas-mediated gene regulation
|
|
US11180793B2
(en)
|
2015-04-24 |
2021-11-23 |
Editas Medicine, Inc. |
Evaluation of Cas9 molecule/guide RNA molecule complexes
|
|
WO2016176617A2
(en)
|
2015-04-29 |
2016-11-03 |
New York University |
Method for treating high-grade gliomas
|
|
CN108026566A
(zh)
|
2015-05-04 |
2018-05-11 |
特拉维夫大学拉莫特有限公司 |
用于使dna片段化的方法和试剂盒
|
|
EP3294896A1
(en)
|
2015-05-11 |
2018-03-21 |
Editas Medicine, Inc. |
Optimized crispr/cas9 systems and methods for gene editing in stem cells
|
|
US10808020B2
(en)
*
|
2015-05-12 |
2020-10-20 |
Sangamo Therapeutics, Inc. |
Nuclease-mediated regulation of gene expression
|
|
US10136649B2
(en)
|
2015-05-29 |
2018-11-27 |
North Carolina State University |
Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids
|
|
WO2016196887A1
(en)
|
2015-06-03 |
2016-12-08 |
Board Of Regents Of The University Of Nebraska |
Dna editing using single-stranded dna
|
|
KR102796744B1
(ko)
|
2015-06-09 |
2025-04-15 |
에디타스 메디신, 인코포레이티드 |
이식의 개선을 위한 crispr/cas-관련 방법 및 조성물
|
|
CN115537421A
(zh)
|
2015-06-15 |
2022-12-30 |
北卡罗来纳州立大学 |
有效递送核酸和基于rna的抗微生物剂的方法和组合物
|
|
EP3929286A1
(en)
*
|
2015-06-17 |
2021-12-29 |
Poseida Therapeutics, Inc. |
Compositions and methods for directing proteins to specific loci in the genome
|
|
WO2016205613A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Crispr enzyme mutations reducing off-target effects
|
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
EP3313445A1
(en)
*
|
2015-06-24 |
2018-05-02 |
Sigma Aldrich Co. LLC |
Cell cycle dependent genome regulation and modification
|
|
CA2993431A1
(en)
|
2015-07-31 |
2017-02-09 |
Regents Of The University Of Minnesota |
Nuclease based knockouts of immunological checkpoint genes in immune cells
|
|
US10709726B2
(en)
|
2015-08-14 |
2020-07-14 |
The University Of Sydney |
Connexin 45 inhibition for therapy
|
|
JP6905755B2
(ja)
|
2015-08-25 |
2021-07-21 |
デューク ユニバーシティ |
Ｒｎａガイド型エンドヌクレアーゼを使用してゲノム工学における特異性を改善する組成物および方法
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
JP6799586B2
(ja)
|
2015-08-28 |
2020-12-16 |
ザ ジェネラル ホスピタル コーポレイション |
遺伝子操作ＣＲＩＳＰＲ−Ｃａｓ９ヌクレアーゼ
|
|
CA2999500A1
(en)
|
2015-09-24 |
2017-03-30 |
Editas Medicine, Inc. |
Use of exonucleases to improve crispr/cas-mediated genome editing
|
|
KR101795999B1
(ko)
|
2015-09-25 |
2017-11-09 |
전남대학교산학협력단 |
Crispr/cas9 시스템을 이용한 베타2-마이크로글로불린 유전자 제거용 시발체
|
|
KR101745863B1
(ko)
|
2015-09-25 |
2017-06-12 |
전남대학교산학협력단 |
Crispr/cas9 시스템을 이용한 프로히비틴2 유전자 제거용 시발체
|
|
WO2017058751A1
(en)
|
2015-09-28 |
2017-04-06 |
North Carolina State University |
Methods and compositions for sequence specific antimicrobials
|
|
WO2017066497A2
(en)
*
|
2015-10-13 |
2017-04-20 |
Duke University |
Genome engineering with type i crispr systems in eukaryotic cells
|
|
FI3846375T3
(fi)
|
2015-10-22 |
2023-01-13 |
|
Menetelmät ja laitteet liittyen radiosignaalien selektiiviseen parantamiseen
|
|
IL294014B2
(en)
|
2015-10-23 |
2024-07-01 |
Harvard College |
Nucleobase editors and uses thereof
|
|
US20180230489A1
(en)
|
2015-10-28 |
2018-08-16 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
GB2559526B
(en)
|
2015-11-03 |
2021-02-17 |
Harvard College |
Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix
|
|
US11905521B2
(en)
|
2015-11-17 |
2024-02-20 |
The Chinese University Of Hong Kong |
Methods and systems for targeted gene manipulation
|
|
US10240145B2
(en)
*
|
2015-11-25 |
2019-03-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer
|
|
CN108779466B
(zh)
|
2015-11-30 |
2024-03-29 |
杜克大学 |
用于通过基因编辑修正人肌营养不良蛋白基因的治疗靶标和使用方法
|
|
US11542466B2
(en)
|
2015-12-22 |
2023-01-03 |
North Carolina State University |
Methods and compositions for delivery of CRISPR based antimicrobials
|
|
NZ743983A
(en)
|
2016-01-11 |
2025-08-29 |
Univ Leland Stanford Junior |
Chimeric proteins and methods of regulating gene expression
|
|
EA201891614A1
(ru)
|
2016-01-11 |
2019-02-28 |
Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити |
Химерные белки и способы иммунотерапии
|
|
EP3219799A1
(en)
|
2016-03-17 |
2017-09-20 |
IMBA-Institut für Molekulare Biotechnologie GmbH |
Conditional crispr sgrna expression
|
|
US11597924B2
(en)
|
2016-03-25 |
2023-03-07 |
Editas Medicine, Inc. |
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
|
|
WO2017165862A1
(en)
|
2016-03-25 |
2017-09-28 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency
|
|
WO2017180915A2
(en)
|
2016-04-13 |
2017-10-19 |
Duke University |
Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use
|
|
EP3443086B1
(en)
|
2016-04-13 |
2021-11-24 |
Editas Medicine, Inc. |
Cas9 fusion molecules, gene editing systems, and methods of use thereof
|
|
EP3443085B1
(en)
*
|
2016-04-14 |
2022-09-14 |
BOCO Silicon Valley, Inc. |
Genome editing of human neural stem cells using nucleases
|
|
JP7148494B2
(ja)
*
|
2016-04-25 |
2022-10-05 |
ウニベルシテート バーゼル |
アレル編集およびその応用
|
|
AU2017257624B2
(en)
|
2016-04-25 |
2023-05-25 |
President And Fellows Of Harvard College |
Hybridization chain reaction methods for in situ molecular detection
|
|
IL262772B2
(en)
*
|
2016-05-06 |
2023-10-01 |
Juno Therapeutics Inc |
Genetically engineered cells and methods of making the same
|
|
CN109475109B
(zh)
|
2016-05-20 |
2021-10-29 |
瑞泽恩制药公司 |
用于使用多个引导rna来破坏免疫耐受性的方法
|
|
GB2582731B8
(en)
*
|
2016-06-02 |
2021-10-27 |
Sigma Aldrich Co Llc |
Using programmable DNA binding proteins to enhance targeted genome modification
|
|
EP3463290A4
(en)
*
|
2016-06-03 |
2019-10-30 |
Temple University - Of The Commonwealth System of Higher Education |
REGULATION OF THE NEGATIVE RECONSTITUTION OF HIV-1 BY GENETIZATION STRATEGY
|
|
US20190185832A1
(en)
*
|
2016-06-03 |
2019-06-20 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Diet controlled expression of a nucleic acid encoding cas9 nuclease and uses thereof
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
US10337051B2
(en)
|
2016-06-16 |
2019-07-02 |
The Regents Of The University Of California |
Methods and compositions for detecting a target RNA
|
|
US11293021B1
(en)
|
2016-06-23 |
2022-04-05 |
Inscripta, Inc. |
Automated cell processing methods, modules, instruments, and systems
|
|
LT3474669T
(lt)
|
2016-06-24 |
2022-06-10 |
The Regents Of The University Of Colorado, A Body Corporate |
Barkodu pažymėtų kombinatorinių bibliotekų generavimo būdai
|
|
US11603533B2
(en)
|
2016-07-12 |
2023-03-14 |
Washington University |
Incorporation of internal polya-encoded poly-lysine sequence tags and their variations for the tunable control of protein synthesis in bacterial and eukaryotic cells
|
|
WO2018017754A1
(en)
|
2016-07-19 |
2018-01-25 |
Duke University |
Therapeutic applications of cpf1-based genome editing
|
|
AU2017302611B2
(en)
|
2016-07-28 |
2021-12-09 |
Regeneron Pharmaceuticals, Inc. |
GPR156 variants and uses thereof
|
|
EP3490373B1
(en)
|
2016-07-29 |
2023-10-25 |
Regeneron Pharmaceuticals, Inc. |
Mice comprising mutations resulting in expression of c-truncated fibrillin-1
|
|
BR112019001887A2
(pt)
|
2016-08-02 |
2019-07-09 |
Editas Medicine Inc |
composições e métodos para o tratamento de doença associada a cep290
|
|
US11078481B1
(en)
|
2016-08-03 |
2021-08-03 |
KSQ Therapeutics, Inc. |
Methods for screening for cancer targets
|
|
AU2017306676B2
(en)
|
2016-08-03 |
2024-02-22 |
President And Fellows Of Harvard College |
Adenosine nucleobase editors and uses thereof
|
|
EP3497214B1
(en)
|
2016-08-09 |
2023-06-28 |
President and Fellows of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
|
EP3500677A4
(en)
*
|
2016-08-20 |
2020-04-01 |
Avellino Lab USA, Inc. |
Single guide rna, crispr/cas9 systems, and methods of use thereof
|
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
US11078483B1
(en)
|
2016-09-02 |
2021-08-03 |
KSQ Therapeutics, Inc. |
Methods for measuring and improving CRISPR reagent function
|
|
WO2018048827A1
(en)
*
|
2016-09-07 |
2018-03-15 |
Massachusetts Institute Of Technology |
Rna-guided endonuclease-based dna assembly
|
|
CN106636197B
(zh)
*
|
2016-09-22 |
2019-09-03 |
南京市妇幼保健院 |
一种定向敲降斑马鱼基因组中多拷贝基因的方法
|
|
US20190225974A1
(en)
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
|
AU2017335890B2
(en)
|
2016-09-30 |
2024-05-09 |
The Regents Of The University Of California |
RNA-guided nucleic acid modifying enzymes and methods of use thereof
|
|
AU2017335883B2
(en)
|
2016-09-30 |
2024-06-13 |
The Regents Of The University Of California |
RNA-guided nucleic acid modifying enzymes and methods of use thereof
|
|
US20190233820A1
(en)
*
|
2016-10-11 |
2019-08-01 |
Stemgenics, Inc. |
Nanoparticles functionalized with gene editing tools and related methods
|
|
EP3525832A4
(en)
|
2016-10-14 |
2020-04-29 |
The General Hospital Corp. |
Epigenetically regulated site-specific nucleases
|
|
WO2018071868A1
(en)
|
2016-10-14 |
2018-04-19 |
President And Fellows Of Harvard College |
Aav delivery of nucleobase editors
|
|
GB201617559D0
(en)
|
2016-10-17 |
2016-11-30 |
University Court Of The University Of Edinburgh The |
Swine comprising modified cd163 and associated methods
|
|
EP4338799A3
(en)
|
2016-10-18 |
2024-06-05 |
Regents of the University of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
CA3041582A1
(en)
*
|
2016-11-02 |
2018-05-11 |
Universitat Basel |
Immunologically discernible cell surface variants for use in cell therapy
|
|
EP3555297A1
(en)
|
2016-12-19 |
2019-10-23 |
Editas Medicine, Inc. |
Assessing nuclease cleavage
|
|
KR102551664B1
(ko)
*
|
2016-12-22 |
2023-07-05 |
인텔리아 테라퓨틱스, 인크. |
알파-1 항트립신 결핍을 치료하기 위한 조성물 및 방법
|
|
JP2020504612A
(ja)
*
|
2016-12-23 |
2020-02-13 |
インスティテュート フォー ベーシック サイエンスＩｎｓｔｉｔｕｔｅ Ｆｏｒ Ｂａｓｉｃ Ｓｃｉｅｎｃｅ |
動物胚の塩基編集用組成物および塩基編集方法
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
US11859219B1
(en)
|
2016-12-30 |
2024-01-02 |
Flagship Pioneering Innovations V, Inc. |
Methods of altering a target nucleotide sequence with an RNA-guided nuclease and a single guide RNA
|
|
EP3565907B1
(en)
|
2017-01-06 |
2022-05-04 |
Editas Medicine, Inc. |
Methods of assessing nuclease cleavage
|
|
WO2018136702A1
(en)
|
2017-01-23 |
2018-07-26 |
Regeneron Pharmaceuticals, Inc. |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
|
US12344826B2
(en)
|
2017-01-25 |
2025-07-01 |
The George Washington University, A Congressionally Chartered Not-For-Profit Corporation |
Apparatus and methods for in vitro preclinical human trials
|
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
|
CN106978438B
(zh)
*
|
2017-02-27 |
2020-08-28 |
北京大北农生物技术有限公司 |
提高同源重组效率的方法
|
|
WO2018165631A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Cancer vaccine
|
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
WO2018170184A1
(en)
|
2017-03-14 |
2018-09-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
KR20240116572A
(ko)
|
2017-03-23 |
2024-07-29 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
|
|
US11913015B2
(en)
|
2017-04-17 |
2024-02-27 |
University Of Maryland, College Park |
Embryonic cell cultures and methods of using the same
|
|
US11834670B2
(en)
|
2017-04-19 |
2023-12-05 |
Global Life Sciences Solutions Usa Llc |
Site-specific DNA modification using a donor DNA repair template having tandem repeat sequences
|
|
EP3612023A4
(en)
|
2017-04-20 |
2021-05-12 |
Egenesis, Inc. |
Methods for generating genetically modified animals
|
|
AU2018254619B2
(en)
|
2017-04-21 |
2022-07-21 |
The General Hospital Corporation |
Variants of Cpf1 (CAS12a) with altered PAM specificity
|
|
EP3615672A1
(en)
|
2017-04-28 |
2020-03-04 |
Editas Medicine, Inc. |
Methods and systems for analyzing guide rna molecules
|
|
WO2018209158A2
(en)
|
2017-05-10 |
2018-11-15 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease systems and methods
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
WO2018218166A1
(en)
|
2017-05-25 |
2018-11-29 |
The General Hospital Corporation |
Using split deaminases to limit unwanted off-target base editor deamination
|
|
CN110997906B
(zh)
|
2017-06-05 |
2024-05-07 |
雷杰纳荣制药公司 |
B4galt1变体及其用途
|
|
CA3065813A1
(en)
|
2017-06-09 |
2018-12-13 |
Editas Medicine, Inc. |
Engineered cas9 nucleases
|
|
CA3067382A1
(en)
|
2017-06-15 |
2018-12-20 |
The Regents Of The University Of California |
Targeted non-viral dna insertions
|
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
US10011849B1
(en)
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
EP4484562A3
(en)
|
2017-06-27 |
2025-03-26 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized asgr1 locus
|
|
EP3645021A4
(en)
|
2017-06-30 |
2021-04-21 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
|
RS63202B1
(sr)
|
2017-06-30 |
2022-06-30 |
Inscripta Inc |
Automatizovani postupci, moduli, instrumenti i sistemi za obradu ćelija
|
|
CA3066790C
(en)
|
2017-07-11 |
2023-07-18 |
Sigma-Aldrich Co. Llc |
Using nucleosome interacting protein domains to enhance targeted genome modification
|
|
EP3652312A1
(en)
|
2017-07-14 |
2020-05-20 |
Editas Medicine, Inc. |
Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
CN115074343A
(zh)
|
2017-07-31 |
2022-09-20 |
瑞泽恩制药公司 |
Cas转基因小鼠胚胎干细胞和小鼠及其应用
|
|
BR112019027673A2
(pt)
|
2017-07-31 |
2020-09-15 |
Regeneron Pharmaceuticals, Inc. |
animal não humano, e, métodos para testar a recombinação induzida por crispr/cas e para otimizar a capacidade de crispr/cas
|
|
CA3066798A1
(en)
*
|
2017-07-31 |
2019-02-07 |
Sigma Aldrich Co. Llc |
Synthetic guide rna for crispr/cas activator systems
|
|
WO2019028023A2
(en)
|
2017-07-31 |
2019-02-07 |
Regeneron Pharmaceuticals, Inc. |
METHODS AND COMPOSITIONS FOR EVALUATING CRISPR / CAS MEDIATED DISRUPTION OR EXCISION AND CRISPR / CAS INDUCED RECOMBINATION USING IN VIVO EXOGENIC DONOR NUCLEIC ACID
|
|
WO2019030695A1
(en)
*
|
2017-08-09 |
2019-02-14 |
Benson Hill Biosystems, Inc. |
Compositions and methods for modifying genomes
|
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
|
EP3678680A4
(en)
|
2017-09-05 |
2021-12-01 |
Regeneron Pharmaceuticals, Inc. |
ADMINISTRATION OF A GENE EDITING SYSTEM CONTAINING A SINGLE RETROVIRAL PARTICLE AND METHODS OF GENERATION AND USE
|
|
SG11202001754RA
(en)
|
2017-09-06 |
2020-03-30 |
Regeneron Pharma |
Single immunoglobulin interleukin-1 receptor related (sigirr) variants and uses thereof
|
|
SG11202001792UA
(en)
|
2017-09-07 |
2020-03-30 |
Regeneron Pharma |
Solute carrier family 14 member 1 (slc14a1) variants and uses thereof
|
|
AU2018338790B2
(en)
|
2017-09-29 |
2022-09-15 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized TTR locus and methods of use
|
|
CN111372650A
(zh)
|
2017-09-30 |
2020-07-03 |
因思科瑞普特公司 |
流通式电穿孔仪器
|
|
US11634716B2
(en)
|
2017-10-16 |
2023-04-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Genetically modified mesenchymal stem cells for use in cardiovascular prosthetics
|
|
AU2018352234A1
(en)
|
2017-10-16 |
2020-04-23 |
Regeneron Pharmaceuticals, Inc. |
Cornulin (CRNN) variants and uses thereof
|
|
WO2019079347A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
USES OF BASIC EDITORS ADENOSINE
|
|
IL305485B2
(en)
|
2017-10-27 |
2025-10-01 |
Univ California |
Targeted replacement of endogenous T cell receptors
|
|
US12227753B2
(en)
|
2017-11-01 |
2025-02-18 |
The Regents Of The University Of California |
CasY compositions and methods of use
|
|
US11970719B2
(en)
|
2017-11-01 |
2024-04-30 |
The Regents Of The University Of California |
Class 2 CRISPR/Cas compositions and methods of use
|
|
CA3080493A1
(en)
|
2017-11-01 |
2019-05-09 |
The Regents Of The University Of California |
Casz compositions and methods of use
|
|
BR112020008627A2
(pt)
|
2017-11-03 |
2020-12-22 |
University Of Florida Research Foundation, Inc. |
Métodos e composições para resistência a patógenos de plantas em plantas
|
|
CN111565566B
(zh)
|
2017-11-10 |
2022-10-21 |
瑞泽恩制药公司 |
包含slc30a8突变的非人动物及使用方法
|
|
CN120310773A
(zh)
*
|
2017-11-16 |
2025-07-15 |
阿斯利康(瑞典)有限公司 |
用于改善基于Cas9的敲入策略的有效性的组合物和方法
|
|
CA3076377A1
(en)
|
2017-11-30 |
2019-06-06 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized trkb locus
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
WO2019126578A1
(en)
*
|
2017-12-20 |
2019-06-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for directing proteins to specific loci in the genome
|
|
US11293019B2
(en)
|
2017-12-22 |
2022-04-05 |
Gflas Life Sciences, Inc. |
Chimeric genome engineering molecules and methods
|
|
BR112020014168A2
(pt)
|
2018-01-12 |
2020-12-08 |
Basf Se |
Proteína, ácido nucleico isolado, gene recombinante, vetor, célula hospedeira, planta, parte de planta ou semente de trigo, métodos para produzir, produto de trigo, farinha, farelo integral, amido, grânulos de amido ou farelo de trigo e métodos para identificar e/ou selecionar uma planta de trigo
|
|
US12509492B2
(en)
|
2018-01-19 |
2025-12-30 |
Duke University |
Genome engineering with CRISPR-Cas systems in eukaryotes
|
|
WO2019147302A1
(en)
*
|
2018-01-26 |
2019-08-01 |
Bauer Daniel E |
Targeting bcl11a distal regulatory elements with a cas9-cas9 fusion for fetal hemoglobin reinduction
|
|
IL274528B2
(en)
|
2018-02-15 |
2025-10-01 |
Sigma Aldrich Co Llc |
Engineered Cas9 systems for eukaryotic genome modification
|
|
US20220010293A1
(en)
|
2018-02-23 |
2022-01-13 |
Pioneer Hi-Bred International, Inc. |
Novel cas9 orthologs
|
|
WO2019178426A1
(en)
|
2018-03-14 |
2019-09-19 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
EP3592140A1
(en)
|
2018-03-19 |
2020-01-15 |
Regeneron Pharmaceuticals, Inc. |
Transcription modulation in animals using crispr/cas systems
|
|
WO2019190874A1
(en)
|
2018-03-29 |
2019-10-03 |
Inscripta, Inc. |
Automated control of cell growth rates for induction and transformation
|
|
WO2019200004A1
(en)
|
2018-04-13 |
2019-10-17 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
|
EP3781705A4
(en)
|
2018-04-19 |
2022-01-26 |
The Regents of the University of California |
COMPOSITIONS AND METHODS OF GENE EDIT
|
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
|
WO2019209926A1
(en)
|
2018-04-24 |
2019-10-31 |
Inscripta, Inc. |
Automated instrumentation for production of peptide libraries
|
|
US10526598B2
(en)
|
2018-04-24 |
2020-01-07 |
Inscripta, Inc. |
Methods for identifying T-cell receptor antigens
|
|
KR20210005178A
(ko)
*
|
2018-04-27 |
2021-01-13 |
시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 |
X-연관 고 igm 증후군에서의 치료적 게놈 편집
|
|
WO2019213430A1
(en)
*
|
2018-05-03 |
2019-11-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for nicking target dna sequences
|
|
CA3098874A1
(en)
|
2018-05-10 |
2019-11-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene therapy methods and compositions using auxotrophic regulatable cells
|
|
CN112105732A
(zh)
*
|
2018-05-10 |
2020-12-18 |
先正达参股股份有限公司 |
用于多核苷酸的靶向编辑的方法和组合物
|
|
CN112534054B
(zh)
|
2018-05-11 |
2025-10-28 |
比姆医疗股份有限公司 |
使用可编程碱基编辑器系统取代病原性氨基酸的方法
|
|
CN108624622A
(zh)
*
|
2018-05-16 |
2018-10-09 |
湖南艾佳生物科技股份有限公司 |
一种基于CRISPR-Cas9系统构建的能分泌小鼠白细胞介素-6的基因工程细胞株
|
|
WO2019222545A1
(en)
|
2018-05-16 |
2019-11-21 |
Synthego Corporation |
Methods and systems for guide rna design and use
|
|
EP3797160A1
(en)
|
2018-05-23 |
2021-03-31 |
The Broad Institute Inc. |
Base editors and uses thereof
|
|
EP3575402A1
(en)
*
|
2018-06-01 |
2019-12-04 |
Algentech SAS |
Gene targeting
|
|
CA3102975A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
|
EP3802839A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
|
EP3810801B1
(en)
*
|
2018-06-25 |
2022-09-28 |
Bionano Genomics, Inc. |
Labeling of dna
|
|
EP3823633A4
(en)
|
2018-06-29 |
2023-05-03 |
Editas Medicine, Inc. |
SYNTHETIC LEAD MOLECULES, COMPOSITIONS AND METHODS RELATED THERETO
|
|
WO2020014261A1
(en)
|
2018-07-09 |
2020-01-16 |
The Broad Institute, Inc. |
Rna programmable epigenetic rna modifiers and uses thereof
|
|
CA3108281A1
(en)
*
|
2018-08-03 |
2020-02-06 |
Beam Therapeutics Inc. |
Multi-effector nucleobase editors and methods of using same to modify a nucleic acid target sequence
|
|
GB201813011D0
(en)
|
2018-08-10 |
2018-09-26 |
Vib Vzw |
Means and methods for drought tolerance in crops
|
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
|
US10752874B2
(en)
|
2018-08-14 |
2020-08-25 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
|
IL292273B2
(en)
|
2018-08-14 |
2023-10-01 |
Inscripta Inc |
Devices, modules and methods for improved detection of edited sequences in living cells
|
|
KR102158428B1
(ko)
*
|
2018-08-16 |
2020-09-22 |
(주)라트바이오 |
인위적 뉴클레아제를 생산하는 형질전환 배아 및 형질전환 동물의 제작 방법
|
|
KR20210046001A
(ko)
*
|
2018-08-21 |
2021-04-27 |
시그마-알드리치 컴퍼니., 엘엘씨 |
시토졸 dna 센서 경로의 하향-조절
|
|
US11965154B2
(en)
|
2018-08-30 |
2024-04-23 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
|
US12454694B2
(en)
|
2018-09-07 |
2025-10-28 |
Beam Therapeutics Inc. |
Compositions and methods for improving base editing
|
|
CN109055379B
(zh)
*
|
2018-09-10 |
2022-04-15 |
石铭 |
一种转基因鸡输卵管生物反应器的制备方法
|
|
KR102121817B1
(ko)
*
|
2018-09-12 |
2020-06-26 |
한국화학연구원 |
Crispr 편집 기술을 이용한 재조합 항원을 발현시키는 벡터 및 이를 동시에 다중 삽입시키는 방법
|
|
WO2020056122A1
(en)
|
2018-09-13 |
2020-03-19 |
Regeneron Pharmaceuticals, Inc. |
Complement factor h gene knockout rat as a model of c3 glomerulopathy
|
|
WO2020072254A1
(en)
|
2018-10-01 |
2020-04-09 |
North Carolina State University |
Recombinant type i crispr-cas system and uses thereof for killing target cells
|
|
WO2020072250A1
(en)
|
2018-10-01 |
2020-04-09 |
North Carolina State University |
Recombinant type i crispr-cas system and uses thereof for genome modification and alteration of expression
|
|
US12203123B2
(en)
|
2018-10-01 |
2025-01-21 |
North Carolina State University |
Recombinant type I CRISPR-Cas system and uses thereof for screening for variant cells
|
|
US10711267B2
(en)
|
2018-10-01 |
2020-07-14 |
North Carolina State University |
Recombinant type I CRISPR-Cas system
|
|
WO2020076976A1
(en)
|
2018-10-10 |
2020-04-16 |
Readcoor, Inc. |
Three-dimensional spatial molecular indexing
|
|
GB2611929B
(en)
|
2018-10-16 |
2023-11-22 |
Blueallele Corp |
Methods for targeted insertion of DNA in genes
|
|
WO2020082046A2
(en)
|
2018-10-18 |
2020-04-23 |
Intellia Therapeutics, Inc. |
Compositions and methods for expressing factor ix
|
|
US11214781B2
(en)
|
2018-10-22 |
2022-01-04 |
Inscripta, Inc. |
Engineered enzyme
|
|
EP3870697A4
(en)
|
2018-10-22 |
2022-11-09 |
Inscripta, Inc. |
GMO ENZYMES
|
|
WO2020086908A1
(en)
*
|
2018-10-24 |
2020-04-30 |
The Broad Institute, Inc. |
Constructs for improved hdr-dependent genomic editing
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
|
BR112021011372A2
(pt)
|
2018-12-14 |
2021-08-31 |
Pioneer Hi-Bred International, Inc. |
Novos sistemas crispr-cas para edição de genoma
|
|
WO2020128478A1
(en)
|
2018-12-19 |
2020-06-25 |
King's College London |
Immunotherapeutic methods and compositions
|
|
SG11202105189RA
(en)
|
2018-12-20 |
2021-06-29 |
Regeneron Pharma |
Nuclease-mediated repeat expansion
|
|
AU2020204917A1
(en)
*
|
2019-01-04 |
2021-08-19 |
The University Of Chicago |
Systems and methods for modulating RNA
|
|
US20220136004A1
(en)
*
|
2019-01-11 |
2022-05-05 |
Chan Zuckerberg Biohub, Inc. |
Targeted In Vivo Genome Modification
|
|
WO2020154500A1
(en)
|
2019-01-23 |
2020-07-30 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
US11946040B2
(en)
|
2019-02-04 |
2024-04-02 |
The General Hospital Corporation |
Adenine DNA base editor variants with reduced off-target RNA editing
|
|
EP3924477A4
(en)
*
|
2019-02-14 |
2023-03-29 |
Metagenomi, Inc. |
ENZYMES WITH RUVC DOMAINS
|
|
US10982200B2
(en)
|
2019-02-14 |
2021-04-20 |
Metagenomi Ip Technologies, Llc |
Enzymes with RuvC domains
|
|
JP2022520104A
(ja)
*
|
2019-02-15 |
2022-03-28 |
シグマ－アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー |
Ｃｒｉｓｐｒ／ｃａｓ融合タンパク質およびシステム
|
|
GB201902277D0
(en)
|
2019-02-19 |
2019-04-03 |
King S College London |
Therapeutic agents
|
|
CA3130789A1
(en)
|
2019-03-07 |
2020-09-10 |
The Regents Of The University Of California |
Crispr-cas effector polypeptides and methods of use thereof
|
|
CN120648640A
(zh)
|
2019-03-18 |
2025-09-16 |
瑞泽恩制药公司 |
用于鉴定tau接种或聚集的基因修饰因子的CRISPR/Cas筛选平台
|
|
ES2969026T3
(es)
|
2019-03-18 |
2024-05-16 |
Regeneron Pharma |
Plataforma de detección de abandonos CRISPR/CAS para revelar vulnerabilidades genéticas asociadas con la agregación de tau
|
|
BR112021018607A2
(pt)
|
2019-03-19 |
2021-11-23 |
Massachusetts Inst Technology |
Métodos e composições para editar sequências de nucleotídeos
|
|
US11001831B2
(en)
|
2019-03-25 |
2021-05-11 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
|
US10815467B2
(en)
|
2019-03-25 |
2020-10-27 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
|
CN118064502A
(zh)
|
2019-04-03 |
2024-05-24 |
瑞泽恩制药公司 |
用于将抗体编码序列插入到安全港基因座中的方法和组合物
|
|
CN113795588B
(zh)
|
2019-04-04 |
2025-02-25 |
瑞泽恩制药公司 |
用于在靶向性载体中无瘢痕引入靶向修饰的方法
|
|
KR102661779B1
(ko)
|
2019-04-04 |
2024-04-30 |
리제너론 파마슈티칼스 인코포레이티드 |
인간화 응고 인자 12 좌위를 포함하는 비-인간 동물
|
|
GB201905360D0
(en)
|
2019-04-16 |
2019-05-29 |
Univ Nottingham |
Fungal strains, production and uses thereof
|
|
EP3956349A1
(en)
|
2019-04-17 |
2022-02-23 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
CN113825838A
(zh)
|
2019-05-10 |
2021-12-21 |
巴斯夫欧洲公司 |
增强植物中基因表达的调节性核酸分子
|
|
KR20220016869A
(ko)
|
2019-06-04 |
2022-02-10 |
리제너론 파마슈티칼스 인코포레이티드 |
베타-슬립 돌연변이를 갖는 인간화 ttr 좌위를 포함하는 비-인간 동물 및 사용 방법
|
|
CN113939593A
(zh)
|
2019-06-06 |
2022-01-14 |
因思科瑞普特公司 |
用于递归的核酸指导的细胞编辑的处治
|
|
CN113939595A
(zh)
|
2019-06-07 |
2022-01-14 |
瑞泽恩制药公司 |
包括人源化白蛋白基因座的非人动物
|
|
EP3813522B1
(en)
|
2019-06-14 |
2025-05-07 |
Regeneron Pharmaceuticals, Inc. |
Models of tauopathy
|
|
US10907125B2
(en)
|
2019-06-20 |
2021-02-02 |
Inscripta, Inc. |
Flow through electroporation modules and instrumentation
|
|
US10920189B2
(en)
|
2019-06-21 |
2021-02-16 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli
|
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
|
EP3783104A1
(en)
*
|
2019-08-20 |
2021-02-24 |
Kemijski Institut |
Coiled-coil mediated tethering of crispr-cas and exonucleases for enhanced genome editing
|
|
WO2021050398A1
(en)
*
|
2019-09-10 |
2021-03-18 |
The Regents Of The University Of California |
Synthetic lethality screening platform for cells undergoing alt
|
|
CN114729382A
(zh)
|
2019-09-12 |
2022-07-08 |
巴斯夫欧洲公司 |
增强植物中基因表达的调节性核酸分子
|
|
AU2020346056A1
(en)
|
2019-09-13 |
2022-03-31 |
Regeneron Pharmaceuticals, Inc. |
Transcription modulation in animals using CRISPR/Cas systems delivered by lipid nanoparticles
|
|
WO2021069387A1
(en)
|
2019-10-07 |
2021-04-15 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
CN110628825A
(zh)
*
|
2019-10-14 |
2019-12-31 |
上海捷易生物科技有限公司 |
一种依赖nhej的报告基因敲入组合物及其使用方法
|
|
EP4054651A1
(en)
|
2019-11-08 |
2022-09-14 |
Regeneron Pharmaceuticals, Inc. |
Crispr and aav strategies for x-linked juvenile retinoschisis therapy
|
|
WO2021102059A1
(en)
|
2019-11-19 |
2021-05-27 |
Inscripta, Inc. |
Methods for increasing observed editing in bacteria
|
|
WO2021108363A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-mediated upregulation of humanized ttr allele
|
|
US12325861B2
(en)
|
2019-12-03 |
2025-06-10 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
|
US10883095B1
(en)
|
2019-12-10 |
2021-01-05 |
Inscripta, Inc. |
Mad nucleases
|
|
US10704033B1
(en)
|
2019-12-13 |
2020-07-07 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
|
WO2021122080A1
(en)
|
2019-12-16 |
2021-06-24 |
BASF Agricultural Solutions Seed US LLC |
Improved genome editing using paired nickases
|
|
JP2023507566A
(ja)
|
2019-12-18 |
2023-02-24 |
インスクリプタ， インコーポレイテッド |
核酸誘導ヌクレアーゼ編集済み細胞のｉｎ ｖｉｖｏ検出のためのカスケード／ｄＣａｓ３相補性アッセイ
|
|
WO2021141890A1
(en)
*
|
2020-01-09 |
2021-07-15 |
Pioneer Hi-Bred International, Inc. |
Two-step gene swap
|
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
|
KR20220133257A
(ko)
|
2020-01-27 |
2022-10-04 |
인스크립타 인코포레이티드 |
전기천공 모듈 및 기구
|
|
WO2021154791A1
(en)
|
2020-01-28 |
2021-08-05 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized pnpla3 locus and methods of use
|
|
EP4099821A1
(en)
|
2020-02-07 |
2022-12-14 |
Regeneron Pharmaceuticals, Inc. |
<smallcaps/>? ? ?klkb1? ? ? ? ?non-human animals comprising a humanizedlocus and methods of use
|
|
AU2021232598A1
(en)
|
2020-03-04 |
2022-09-08 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for sensitization of tumor cells to immune therapy
|
|
WO2021195079A1
(en)
|
2020-03-23 |
2021-09-30 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
|
|
WO2021202568A1
(en)
|
2020-03-31 |
2021-10-07 |
Metagenomi Ip Technologies, Llc |
Class ii, type ii crispr systems
|
|
WO2021202938A1
(en)
|
2020-04-03 |
2021-10-07 |
Creyon Bio, Inc. |
Oligonucleotide-based machine learning
|
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
|
AU2021267940A1
(en)
|
2020-05-08 |
2022-12-08 |
President And Fellows Of Harvard College |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
|
EP4171215A2
(en)
|
2020-06-26 |
2023-05-03 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ace2 locus
|
|
CN111849986A
(zh)
*
|
2020-07-24 |
2020-10-30 |
江苏集萃药康生物科技有限公司 |
一种减少CRISPR-Cas9基因编辑中双链DNA片段串联的方法及其应用
|
|
US20220049303A1
(en)
|
2020-08-17 |
2022-02-17 |
Readcoor, Llc |
Methods and systems for spatial mapping of genetic variants
|
|
WO2022060749A1
(en)
|
2020-09-15 |
2022-03-24 |
Inscripta, Inc. |
Crispr editing to embed nucleic acid landing pads into genomes of live cells
|
|
US11512297B2
(en)
|
2020-11-09 |
2022-11-29 |
Inscripta, Inc. |
Affinity tag for recombination protein recruitment
|
|
WO2022120022A1
(en)
|
2020-12-02 |
2022-06-09 |
Regeneron Pharmaceuticals, Inc. |
Crispr sam biosensor cell lines and methods of use thereof
|
|
US20240058390A1
(en)
*
|
2020-12-16 |
2024-02-22 |
The Administrators Of The Tulane Educational Fund |
Wnt+ adipocytes, exosomes from wnt+ adipocytes, and methods of making and using them
|
|
AU2021415461A1
(en)
|
2021-01-04 |
2023-08-17 |
Inscripta, Inc. |
Mad nucleases
|
|
US20240376451A1
(en)
|
2021-01-07 |
2024-11-14 |
Inscripta, Inc. |
Mad nucleases
|
|
BR112023014719A2
(pt)
*
|
2021-01-22 |
2023-12-05 |
Metagenomi Inc |
Novas nucleases quiméricas e manipuladas
|
|
AU2022216614A1
(en)
|
2021-02-05 |
2023-02-23 |
Christiana Care Gene Editing Institute, Inc. |
Methods of and compositions for reducing gene expression and/or activity
|
|
US11884924B2
(en)
|
2021-02-16 |
2024-01-30 |
Inscripta, Inc. |
Dual strand nucleic acid-guided nickase editing
|
|
GB202103131D0
(en)
|
2021-03-05 |
2021-04-21 |
Biosystems Tech Limited |
Method for preparation of research organisms
|
|
EP4337769A1
(en)
|
2021-05-10 |
2024-03-20 |
SQZ Biotechnologies Company |
Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
|
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
|
EP4347826A1
(en)
|
2021-06-02 |
2024-04-10 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
|
MX2024002539A
(es)
|
2021-08-27 |
2024-03-19 |
Metagenomi Inc |
Enzimas con dominios ruvc.
|
|
CA3230927A1
(en)
|
2021-09-10 |
2023-03-16 |
Agilent Technologies, Inc. |
Guide rnas with chemical modification for prime editing
|
|
WO2023064924A1
(en)
|
2021-10-14 |
2023-04-20 |
Codiak Biosciences, Inc. |
Modified producer cells for extracellular vesicle production
|
|
AU2022366987A1
(en)
|
2021-10-14 |
2024-05-16 |
Arsenal Biosciences, Inc. |
Immune cells having co-expressed shrnas and logic gate systems
|
|
US20240415980A1
(en)
|
2021-10-28 |
2024-12-19 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-related methods and compositions for knocking out c5
|
|
AU2022375820A1
(en)
|
2021-11-01 |
2024-06-13 |
Tome Biosciences, Inc. |
Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo
|
|
IL312505A
(en)
|
2021-11-04 |
2024-07-01 |
Regeneron Pharma |
Non-human animals comprising a modified cacng1 locus
|
|
WO2023097282A1
(en)
|
2021-11-24 |
2023-06-01 |
Metagenomi, Inc. |
Endonuclease systems
|
|
AU2022408167A1
(en)
|
2021-12-08 |
2024-06-06 |
Regeneron Pharmaceuticals, Inc. |
Mutant myocilin disease model and uses thereof
|
|
GB202118058D0
(en)
|
2021-12-14 |
2022-01-26 |
Univ Warwick |
Methods to increase yields in crops
|
|
US20230279442A1
(en)
|
2021-12-15 |
2023-09-07 |
Versitech Limited |
Engineered cas9-nucleases and method of use thereof
|
|
EP4451863A1
(en)
|
2021-12-20 |
2024-10-30 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising humanized ace2 and tmprss loci
|
|
AU2022420615A1
(en)
|
2021-12-22 |
2024-07-04 |
Tome Biosciences, Inc. |
Co-delivery of a gene editor construct and a donor template
|
|
JP2025501221A
(ja)
|
2021-12-29 |
2025-01-17 |
ブリストル－マイヤーズ スクイブ カンパニー |
ランディングパッド細胞株の生成
|
|
WO2023150181A1
(en)
|
2022-02-01 |
2023-08-10 |
President And Fellows Of Harvard College |
Methods and compositions for treating cancer
|
|
US20250032642A1
(en)
|
2022-02-02 |
2025-01-30 |
Regeneron Pharmaceuticals, Inc. |
Crispr-mediated transgene insertion in neonatal cells
|
|
EP4475671A1
(en)
|
2022-02-07 |
2024-12-18 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for defining optimal treatment timeframes in lysosomal disease
|
|
WO2023205744A1
(en)
|
2022-04-20 |
2023-10-26 |
Tome Biosciences, Inc. |
Programmable gene insertion compositions
|
|
JP2025514304A
(ja)
|
2022-04-29 |
2025-05-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
遺伝子治療法のための組織特異的遺伝子外セーフハーバーの同定
|
|
WO2023215831A1
(en)
|
2022-05-04 |
2023-11-09 |
Tome Biosciences, Inc. |
Guide rna compositions for programmable gene insertion
|
|
JP2025516527A
(ja)
|
2022-05-09 |
2025-05-30 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
インビボ抗体産生のためのベクター及び方法
|
|
AU2023273885A1
(en)
|
2022-05-19 |
2024-12-05 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
|
WO2023225670A2
(en)
|
2022-05-20 |
2023-11-23 |
Tome Biosciences, Inc. |
Ex vivo programmable gene insertion
|
|
WO2023235726A2
(en)
|
2022-05-31 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Crispr interference therapeutics for c9orf72 repeat expansion disease
|
|
WO2023235725A2
(en)
|
2022-05-31 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Crispr-based therapeutics for c9orf72 repeat expansion disease
|
|
WO2023250384A2
(en)
*
|
2022-06-22 |
2023-12-28 |
The Regents Of The University Of California |
Crispr-cas effector polypeptides and methods of use thereof
|
|
IL317874A
(en)
|
2022-06-24 |
2025-02-01 |
Tune Therapeutics Inc |
Compounds, systems and methods for reducing low density lipoproteins through targeted gene suppression
|
|
GB2621813A
(en)
|
2022-06-30 |
2024-02-28 |
Univ Newcastle |
Preventing disease recurrence in Mitochondrial replacement therapy
|
|
WO2024020587A2
(en)
|
2022-07-22 |
2024-01-25 |
Tome Biosciences, Inc. |
Pleiopluripotent stem cell programmable gene insertion
|
|
WO2024026474A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
|
AU2023316646A1
(en)
|
2022-07-29 |
2024-12-12 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a modified transferrin receptor locus
|
|
KR20250044256A
(ko)
|
2022-08-05 |
2025-03-31 |
리제너론 파마슈티칼스 인코포레이티드 |
Tdp-43의 응집 저항성 변이체
|
|
WO2024064952A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells overexpressing c-jun
|
|
WO2024064958A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
|
IL319122A
(en)
|
2022-09-28 |
2025-04-01 |
Regeneron Pharma |
Different antibody-resistant receptors improve cell-based therapies
|
|
WO2024077174A1
(en)
|
2022-10-05 |
2024-04-11 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
|
WO2024083579A1
(en)
|
2022-10-20 |
2024-04-25 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
|
IL320016A
(en)
|
2022-11-04 |
2025-06-01 |
Regeneron Pharma |
Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
|
|
US20240173426A1
(en)
|
2022-11-14 |
2024-05-30 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|
|
EP4619420A1
(en)
|
2022-11-16 |
2025-09-24 |
Regeneron Pharmaceuticals, Inc. |
Chimeric proteins comprising membrane bound il-12 with protease cleavable linkers
|
|
WO2024138194A1
(en)
|
2022-12-22 |
2024-06-27 |
Tome Biosciences, Inc. |
Platforms, compositions, and methods for in vivo programmable gene insertion
|
|
US12415172B2
(en)
|
2022-12-22 |
2025-09-16 |
Synthego Corporation |
Systems and method for automated oligonucleotide synthesis
|
|
IL321908A
(en)
|
2023-01-27 |
2025-09-01 |
Regeneron Pharma |
Different rhabdomyovirus glycoproteins and their use
|
|
WO2024234006A1
(en)
|
2023-05-11 |
2024-11-14 |
Tome Biosciences, Inc. |
Systems, compositions, and methods for targeting liver sinusodial endothelial cells (lsecs)
|
|
WO2024259309A1
(en)
|
2023-06-15 |
2024-12-19 |
Regeneron Pharmaceuticals, Inc. |
Gene therapy for hearing disorders
|
|
WO2025006963A1
(en)
|
2023-06-30 |
2025-01-02 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for increasing homology-directed repair
|
|
TW202519551A
(zh)
|
2023-07-28 |
2025-05-16 |
美商雷傑納榮製藥公司 |
用於治療酸性神經髓磷脂酶缺乏症之抗ＴｆＲ：酸性神經髓磷脂酶
|
|
WO2025029654A2
(en)
|
2023-07-28 |
2025-02-06 |
Regeneron Pharmaceuticals, Inc. |
Use of bgh-sv40l tandem polya to enhance transgene expression during unidirectional gene insertion
|
|
WO2025029657A2
(en)
|
2023-07-28 |
2025-02-06 |
Regeneron Pharmaceuticals, Inc. |
Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe disease
|
|
WO2025038750A2
(en)
|
2023-08-14 |
2025-02-20 |
President And Fellows Of Harvard College |
Methods and compositions for treating cancer
|
|
WO2025049524A1
(en)
|
2023-08-28 |
2025-03-06 |
Regeneron Pharmaceuticals, Inc. |
Cxcr4 antibody-resistant modified receptors
|
|
WO2025050069A1
(en)
|
2023-09-01 |
2025-03-06 |
Tome Biosciences, Inc. |
Programmable gene insertion using engineered integration enzymes
|
|
GB202314578D0
(en)
|
2023-09-22 |
2023-11-08 |
Univ Manchester |
Methods of producing homoplasmic modified plants or parts thereof
|
|
WO2025122754A1
(en)
|
2023-12-07 |
2025-06-12 |
Regeneron Pharmaceuticals, Inc. |
Gaa knockout non-human animals
|
|
WO2025184567A1
(en)
|
2024-03-01 |
2025-09-04 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host anti-aav antibody response
|
|
WO2025217398A1
(en)
|
2024-04-10 |
2025-10-16 |
Lyell Immunopharma, Inc. |
Methods for culturing cells with improved culture medium
|
|
EP4677108A1
(en)
|
2024-04-22 |
2026-01-14 |
Basecamp Research Ltd |
Method and compositions for detecting off-target editing
|
|
WO2025224182A2
(en)
|
2024-04-23 |
2025-10-30 |
Basecamp Research Ltd |
Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo
|
|
WO2025235388A1
(en)
|
2024-05-06 |
2025-11-13 |
Regeneron Pharmaceuticals, Inc. |
Transgene genomic identification by nuclease-mediated long read sequencing
|
|
WO2025259669A1
(en)
|
2024-06-10 |
2025-12-18 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for characterizing modified oligonucleotides
|
|
WO2025265017A1
(en)
|
2024-06-20 |
2025-12-26 |
Regeneron Pharmaceuticals, Inc. |
Ass1 gene insertion for the treatment of citrullinemia type i
|
|
WO2026006542A2
(en)
|
2024-06-26 |
2026-01-02 |
Yale University |
Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome
|